IDH1 and IDH2 are the most frequently mutated metabolic genes in human cancer, and their mutations have been identified in different types of cancer, notably in gliomas, secondary glioblastomas, cartilaginous and bone tumors, and acute myeloid leukemia (236, 250–252). This evidence concerns the gene IDH1 and cancer.